| Literature DB >> 36079620 |
Siwar Ghannay1, Kaïss Aouadi1,2, Adel Kadri3,4, Mejdi Snoussi5,6.
Abstract
Cuminum cyminum L. essential oil (cumin EO) was studied for its chemical composition, antioxidant and vibriocidal activities. Inhibition of biofilm formation and secretion of some virulence properties controlled by the quorum sensing system in Chromobacterium violaceum and Pseudomonas aeruginosa strains were also reported. The obtained results showed that cuminaldehyde (44.2%) was the dominant compound followed by β-pinene (15.1%), γ-terpinene (14.4%), and p-cymene (14.2%). Using the disc diffusion assay, cumin EO (10 mg/disc) was particularly active against all fifteen Vibrio species, and the highest diameter of growth inhibition zone was recorded against Vibrio fluvialis (41.33 ± 1.15 mm), Vibrio parahaemolyticus (39.67 ± 0.58 mm), and Vibrio natrigens (36.67 ± 0.58 mm). At low concentration (MICs value from 0.023-0.046 mg/mL), cumin EO inhibited the growth of all Vibrio strains, and concentrations as low as 1.5 mg/mL were necessary to kill them (MBCs values from 1.5-12 mg/mL). Using four antioxidant assays, cumin EO exhibited a good result as compared to standard molecules (DPPH = 8 ± 0.54 mg/mL; reducing power = 3.5 ± 0.38 mg/mL; β-carotene = 3.8 ± 0.34 mg/mL; chelating power = 8.4 ± 0.14 mg/mL). More interestingly, at 2x MIC value, cumin EO inhibited the formation of biofilm by Vibrio alginolyticus (9.96 ± 1%), V. parahaemolyticus (15.45 ± 0.7%), Vibrio cholerae (14.9 ± 0.4%), and Vibrio vulnificus (18.14 ± 0.3%). In addition, cumin EO and cuminaldehyde inhibited the production of violacein on Lauria Bertani medium (19 mm and 35 mm, respectively). Meanwhile, 50% of violacein inhibition concentration (VIC50%) was about 2.746 mg/mL for cumin EO and 1.676 mg/mL for cuminaldehyde. Moreover, elastase and protease production and flagellar motility in P. aeruginosa were inhibited at low concentrations of cumin EO and cuminaldehyde. The adopted in-silico approach revealed good ADMET properties as well as a high binding score of the main compounds with target proteins (1JIJ, 2UV0, 1HD2, and 3QP1). Overall, the obtained results highlighted the effectiveness of cumin EO to prevent spoilage with Vibrio species and to interfere with the quorum sensing system in Gram-negative bacteria by inhibiting the flagellar motility, formation of biofilm, and the secretion of some virulence enzymes.Entities:
Keywords: Cuminum cyminum L.; Vibrio spp.; antioxidant; in silico approach; phytochemistry
Year: 2022 PMID: 36079620 PMCID: PMC9459890 DOI: 10.3390/plants11172236
Source DB: PubMed Journal: Plants (Basel) ISSN: 2223-7747
Chemical composition of C. cyminum L. (seeds) EO assessed by GC/MS technique. a: Linear Retention Index.
| Code | Components | l.r.i. a | Percentage | Molecular Weight | Chemical Formula |
|---|---|---|---|---|---|
|
| α-thujene | 933 | 0.4 | 136.23 | C10H16 |
|
| α-pinene | 941 | 0.9 | 136.23 | C10H16 |
|
| Sabinene | 978 | 0.3 | 136.23 | C10H16 |
|
| β- |
|
| 136.238 | C10H16 |
|
| Myrcene | 993 | 0.6 | 136.238 | C10H16 |
|
| α-phellandrene | 1006 | 0.3 | 136.23 | C10H16 |
|
|
|
|
| 134.22 | C10H14 |
|
| Limonene | 1032 | 0.5 | 136.24 | C10H16 |
|
|
|
|
| 136.234 | C10H16 |
|
| Linalool | 1101 | 0.1 | 154.253 | C10H18O |
|
| 4-terpineol | 1179 | 0.4 | 154.25 | C10H18O |
|
| α-terpineol | 1191 | 0.2 | 154.25 | C10H18O |
|
|
|
|
| 148.205 | C10H12O |
|
| Carvone | 1242 | 0.1 | 150.22 | C10H14O |
|
| Phellandral | 1274 | 0.2 | 152.23 | C10H16O |
|
|
|
|
| 150.22 | C10 H14O |
|
| γ- |
|
| 150.22 | C10H14O |
|
| β-caryophyllene | 1419 | 0.3 | 204.36 | C15H24 |
|
| γ-muurolene | 1478 | 0.4 | 204.35 | C15H24 |
|
| Carotol | 1595 | 0.4 | 222.37 | C15H26O |
|
| |||||
| Monoterpene hydrocarbons | 46.7% | ||||
| Oxygenated monoterpenes | 51.3% | ||||
| Sesquiterpene hydrocarbons | 0.7% | ||||
| Oxygenated sesquiterpenes | 0.4% | ||||
|
|
| ||||
Antioxidant activities of cumin EO. The letters (a–c) indicate a significant difference between the different antioxidant methods according to the Duncan test (p < 0.05).
| Antioxidant Tests | Cumin EO | AA | BHT | BHA |
|---|---|---|---|---|
|
| 8 ± 0.54 b | 12 ± 0.01 a | 11.50 ± 0.62 a | - |
|
| 3.50 ± 0.03 c | 25 ± 0.01 a | 23.00 ± 1.0 b | - |
|
| 3.80 ± 0.34 b | - | 4.60 ± 1.60 a | - |
|
| 8.40 ± 0.14 b | - | - | 32.50 ± 1.32 a |
Mean diameter of inhibition zone (mIZ ± mm), MICs, MBCs, and MBC/MIC ratio determination by disc diffusion and microdilution assays. The letters (a–k) indicate a significant difference between the different mZI according to the Duncan test (p < 0.05).
| Cumin EO | ||||
|---|---|---|---|---|
| mZI ± SD | MIC ± SD | MBC ± SD | MBC/MIC Ratio | |
| 34.33 ± 0.58 ef | 0.023 | 6 | >4; Bacteriostatic | |
| 30.33 ± 0.58 g | 0.023 | 1.5 | >4; Bacteriostatic | |
| 39.67 ± 0.58 b | 0.046 | 12 | >4; Bacteriostatic | |
| 28.67 ± 1.15 h | 0.023 | 1.5 | >4; Bacteriostatic | |
| 34.67 ± 0.58 de | 0.023 | 3 | >4; Bacteriostatic | |
| 33.33 ± 0.58 f | 0.023 | 6 | >4; Bacteriostatic | |
| 11.33 ± 0.58 k | 0.023 | 3 | >4; Bacteriostatic | |
| 14.67 ± 0.28 j | 0.046 | 12 | >4; Bacteriostatic | |
| 30.33 ± 0.58 g | 0.023 | 6 | >4; Bacteriostatic | |
| 36.67 ± 0.58 c | 0.023 | 3 | >4; Bacteriostatic | |
| 28.67 ± 0.58 h | 0.046 | 12 | >4; Bacteriostatic | |
| 41.33 ± 1.15 a | 0.046 | 3 | >4; Bacteriostatic | |
| 35.33 ± 0.58 d | 0.046 | 6 | >4; Bacteriostatic | |
| 35.67 ± 0.58 cd | 0.023 | 3 | >4; Bacteriostatic | |
| 11.00 ± 0.00 k | 0.023 | 3 | >4; Bacteriostatic | |
| 30.67 ± 0.58 g | 0.046 | 6 | >4; Bacteriostatic | |
| 26.33 ± 0.58 i | 0.046 | 6 | >4; Bacteriostatic | |
Figure 1Evaluation of the percentage of biofilm formation inhibition tested by using the colorimetric XTT technique against V. alginolyticus ATCC 33787, V. parahaemolyticus ATCC 17802, V. vulnificus ATCC 27962, and V. cholerae ATCC 9459. Errors bars represent standard deviation from three determinations.
Figure 2Violacein inhibition by cumin EO (A) and its main component (cuminaldehyde, B).
Swarming inhibition on Lauria Bertani (0.5% agar-agar) by cumin EO and cuminaldehyde. The letters (a–f) indicate a significant difference between the diameter of colony tested at different concentrations according to the Duncan test (p < 0.05).
| Control | Concentrations Tested (mg/mL) | |||||
|---|---|---|---|---|---|---|
| 10 | 50 | 125 | 250 | 500 | ||
|
| ||||||
|
| 54.00 ± 0.00 a | 19.33 ± 0.57 b | 14.67 ± 0.57 c | 12.00 ± 0.00 d | 10.33 ± 0.57 e | 8.67 ± 0.57 f |
|
| 54.00 ± 0.00 a | 15.67 ± 0.57 b | 13.67 ± 0.57 c | 12.00 ± 0.00 d | 10.33 ± 0.57 e | 9.00 ± 0.00 f |
|
| ||||||
|
| 100 ± 0.00 | 64.20 ± 0.57 | 77.15 ± 0.57 | 84.45 ± 0.00 | 87.76 ± 0.57 | 90.12 ± 0.57 |
|
| 100 ± 0.00 | 70.99 ± 0.57 | 80.75 ± 0.57 | 85.96 ± 0.57 | 87.98 ± 0.57 | 89.77 ± 0.00 |
Figure 3Inhibition of the proteolytic activity (A) and elastolytic activity (B) in P. aeruginosa PAO1 strain by different concentration of cumin EO and cuminaldehyde. Values are the average of at least three independent determinations. Means followed by the same letters are not significantly different at p < 0.05 based on Duncan’s multiple range test.
ADMET properties of compounds the major phytocompounds. Number of the compounds are same listed in Table 1.
| Entry | 4 | 7 | 9 | 13 | 16 | 17 | Reference |
|---|---|---|---|---|---|---|---|
|
| |||||||
| Water solubility | −4.221 | −5.163 | −3.941 | −3.923 | −2.79 | −2.79 | - |
| Caco2 permeability | 1.373 | 1.399 | 1.414 | 1.503 | 1.517 | 1.517 | >0.9 |
| Intestinal absorption (human) | 94.607 | 94.256 | 96.219 | 95.543 | 97.506 | 97.506 | <30% is poorly |
| Skin Permeability (log Kp) | −1.646 | −1.2 | −1.489 | −1.425 | −2.624 | −2.624 | >−2.5 is low |
|
| |||||||
| P-glycoprotein substrate | No | No | No | No | No | No | No |
| P-glycoprotein I inhibitor | No | No | No | No | No | No | No |
| P-glycoprotein II inhibitor | No | No | No | No | No | No | No |
| VDss (human) | 0.68 | 0.455 | 0.412 | 0.274 | 0.233 | 0.233 | Low is <−0.15, High is >0.45 |
| Fraction unbound (human) | 0.353 | 0.262 | 0.42 | 0.305 | 0.465 | 0.465 | - |
| BBB permeability | 0.812 | 0.785 | 0.754 | 0.664 | 0.633 | 0.633 | Poorly is <−1, High is >0.3 |
| CNS permeability | −1.837 | −1.359 | −2.049 | −1.506 | −2.197 | −2.197 | Penetrate is >−2, Unable is <−3 |
|
| |||||||
| CYP2D6 substrate | No | No | No | No | No | No | No |
| CYP3A4 substrate | No | No | No | No | No | No | - |
| CYP1A2 inhibitior | No | No | No | No | No | No | No |
| CYP2C19 inhibitior | No | No | No | No | No | No | No |
| CYP2C9 inhibitior | No | No | No | No | No | No | No |
| CYP2D6 inhibitior | No | No | No | No | No | No | No |
| CYP3A4 inhibitior | No | No | No | No | No | No | No |
|
| |||||||
| Total Clearance | 0.03 | 1.163 | 0.217 | 0.212 | 0.182 | 0.182 | - |
| Renal OCT2 substrate | No | No | No | No | No | No | - |
|
| |||||||
| AMES toxicity | No | No | No | No | No | No | No |
| Max. tolerated dose (human) | 0.24 | 0.193 | 0.756 | 0.128 | 0.723 | 0.723 | Low is ≤0.477, High is >0.477 |
| hERG I inhibitor | No | No | No | No | No | No | No |
| hERG II inhibitor | No | No | No | No | No | No | No |
| Oral Rat Acute Toxicity (LD50) | 1.617 | 1.533 | 1.766 | 1.499 | 1.971 | 1.971 | - |
| Oral Rat Chronic Toxicity (LOAEL) | 2.247 | 2.411 | 2.394 | 2.052 | 2.034 | 2.034 | - |
| Hepatotoxicity | No | No | No | No | No | No | No |
| Skin Sensitisation | No | No | No | Yes | Yes | Yes | No |
| 0.633 | 0.767 | 0.627 | 0.765 | 0.732 | 0.732 | >−0.5 is toxic | |
| Minnow toxicity | 1.131 | 0.65 | 0.906 | 0.862 | 1.118 | 1.118 | <−0.3 is toxic |
Best phytoconstituents identified from C. cyminum L. EO with the lowest binding energies and their interaction residues with selected target proteins.
| Compounds | Interacting Residues | Binding Energy |
|---|---|---|
| β-pinene vs. 1HD2 | −4.6 | |
| Cuminaldehyde vs. 1HD2 | −5.4 | |
| Cuminaldehyde vs. 1JIJ | −7.4 | |
| β-Caryophyllene vs. IJIJ | −6.4 | |
| −7.4 | ||
| γ-Terpinene vs. 2UV0 | −7.4 | |
| Cuminaldehyde vs. 2UV0 | −7.4 | |
| −7.5 | ||
| γ-Terpinene vs. 3QP1 | −7.5 | |
| Cuminaldehyde vs. 3QP1 | −7.2 |
Figure 4Two-dimensional (2D) and three-dimensional (3D) docking pose of cuminaldehyde in active site of tyrosyl-tRNA synthetase (PDB Id: 1JIJ) enzyme.
Figure 5Two-dimensional (2D) and three-dimensional (3D) docking pose of β-pinene in active site of Human PRDX5 antioxidant enzyme (PDB ID, 1HD2).
Figure 6Two-dimensional (2D) and three-dimensional (3D) docking pose of p-cymene in active site of LasR (A) and CviR (B) enzymes.
Review of the chemical composition of C. cyminum EO from seeds.
| Origin | Chemical Composition (Main Constituents) | References |
|---|---|---|
|
| Cuminaldehyde (36.31%), cuminic alcohol (16.92%), γ-terpinene (11.14%), safranal (10.87%), | [ |
|
| α-pinene (29.1%), limonene (21.5%), 1,8-cineole (17.9%), and linalool (10.4%) | [ |
| Cuminaldehyde (25.2%), p-mentha-1,3-dien-7-al (13%), p-mentha-1,4-dien-7-al (16.6%), γ-terpinene (19%), p-cymene (7.2%), and β-pinene (10.4%). | [ | |
| α-Pinene (29.2%), limonene (21.7%), 1,8-cineole (18.1%), linalool (10.5%), linalyl acetate (4.8%), and α-terpineole (3.17%). | [ | |
| α-pinene (30.12%), limonene (10.11%), 1,8-cineole (11.54%), γ-terpinene (3.56%), linalool (10.3%), sabinene (1.11%), | [ | |
| Cuminaldehyde (28.24%), γ-terpinene (21.39%), o-Cymene (13.78%), β-pinene (3.14%), and β-Acoradiene (1.68%). | [ | |
| 3-caren-10-al (47.27%), cuminal (25.92%), 2-caren-10-al (8.05%), γ-terpinene (7.66%), (-)-β-pinene (5.11%), and | [ | |
| Cuminaldehyde (38.26%), α,β-dihydroxy ethylbenzene (29.16%), 2-caren-10-al (11.20%), γ-terpinene (6.49%), and β-pinene (5.25%). | [ | |
| Cuminaldehyde (29.0%), α-terpinen-7-al (20.7%), γ-terpinene (12.94%), γ-terpinen-7-al (8.91%), | [ | |
|
| Safranal (16.8–29.0%), γ-terpinene (14.1–19.6%), γ-terpinene-7-al (13.5–25.5%), cuminaldehyde (17.5–22.3%), β-pinene (6.8–10.4%), and | [ |
| Cuminaldehyde (49.4%), | [ | |
| Cuminaldehyde (36.67%), caren-10-al (21.34%), β-pinene (18.76%), γ-terpinene (16.86%), terpinen-4-ol (2.44%), α-thujene (1.88%), α-pinene (1.41%), | [ | |
|
| Cuminaldehyde (44.53%), | [ |
|
| Cumin aldehyde (33.94%), α-terpinen-7-al (32.20%), γ-terpinen-7-al (13.74%), γ-terpinene (6.67%), β-pinene (5.34%) and | [ |
| Cuminaldehyde (27.10%), β-pinene (25.04%) and γ-terpinene (15.68%). | [ | |
|
| γ-terpinen (25.58%), 1-phenyl-1,2 ethanediol (23.16%), cuminaldehyde (15.31%), β-pinene (15.16%), and ρ-cymene (9.05%) | [ |
| Cuminaldehyde (39.48%), γ-terpinene (15.21%), O-cymene (11.82%), β-pinene (11.13%), 2-caren-10-al 7.93%), trans-carveol (4.49%) and myrtenal (3.5%). | [ | |
| Cuminaldehyde (28.22%), 1-phenyl-1-butanol (23.33%), β-pinene (12.61%) and | [ | |
|
| 2-Caren-10-al (29.64%), benzaldehyde, 4-1-methyethyl (16.58%), and 2-J-pinene (12.06%) | [ |
|
| Cuminaldehyde (34.11%), Δ2-Caren-10-al (20.78%), | [ |
|
| Cuminaldehyde (41.5%), | [ |
|
| Cuminaldehyde (29.3%), γ-Terpinene (18.5%), β-pinene (15.7%), | |
|
| γ-Terpinene (31.1%), cuminaldehyde (23.2%), | |
|
| γ-Terpinene (26.5%), cuminaldehyde (22.4%), | |
|
| β-pinene (20.8–86.4%), | [ |
Review of the antibacterial activities of some EO against Vibrio species.
| Plant Species Tested | References | |
|---|---|---|
|
|
| [ |
|
| [ | |
|
|
| [ |
|
|
| [ |
| [ | ||
|
| [ | |
|
| [ | |
| [ | ||
|
| [ | |
|
| [ | |
|
|
| [ |
|
|
| [ |
| [ | ||
|
| [ | |
| [ | ||
|
|
| [ |
|
| [ | |
|
| [ | |
|
| [ | |
| [ | ||
|
|
| [ |
| [ | ||
| Clove, thyme, garlic |
| [ |
| [ | ||
|
| [ |